Skip to content

SanaClis

Active Private limited companyfounded 2024active for 2 yearsWetenschapspark 11, 3590 DiepenbeekKBO/BCE: BE 1010.302.411

Board

2 directors, since incorporation
Director (not named in the articles)
since 12-06-2024 term without a fixed end
listed in the 2025 annual accounts, filed on 19-06-2026
Director (not named in the articles)
since 12-06-2024 term without a fixed end
listed in the 2025 annual accounts, filed on 19-06-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Artikel 12. Bevoegdheden van het bestuursorgaan Als er slechts één bestuurder is, is het geheel van de bevoegdheden van de bestuurders…”
deed of 14-06-2024

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today
FETKOVSKY Alexander
Director (not named in the articles)
HRYNCHUK Roman
Director (not named in the articles)
Board
Mandates as a list
  • FETKOVSKY Alexander
    • Director (not named in the articles), from 12-06-2024 to date
  • HRYNCHUK Roman
    • Director (not named in the articles), from 12-06-2024 to date

Control

This company
SanaClis
Equity -€29,357
Loss €31,824 in 2025

Capital

Contribution
€50,000
Shares
100
Contribution per share
€500
Equity per share
-€294 in 2025
Source
deed of 14-06-2024

Articles of association

deed of 14-06-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
15 June at 14:00

Founders

Next steps